Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
ON July 21, as Biogen chief executive officer George Scangos announced he would step down, he floated the idea that his company might buy rivals to cement its place near the top of the booming field of biotechnology. Today, Biogen looks more like prey than predator.